 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company Nasdaq: ANIP today announced that it has signed a definitive agreement to acquire Novitium Pharma, a privately held, New Jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities for 163.5 million, including 89.5 million in cash and 74 million in equity plus two potential future cash earn-outs of up to 46.5 million. The transaction has been approved by the ANI 